Spots Global Cancer Trial Database for A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Official Title: Real World Outcome Analysis for APAC High Risk Localized Prostate Cancer Patients Treated With Radical Prostatectomy and Perioperative Hormonal Therapy
Study ID: NCT05303558
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to evaluate the yearly conditional prostate-specific antigen (PSA) progression-free survival (PFS) probabilities in high-risk localized prostate cancer (HR LPC) participants following radical prostatectomy (RP) and perioperative hormonal therapies (that is, hormonal treatment before RP and / or after RP) over 5 years.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Akita University Hospital, Akita, , Japan
Hirosaki University Hospital, Hirosaki, , Japan
Nagoya City University Hospital, Nagoya-shi, , Japan
Yokohama City University Hospital, Yokohama, , Japan
Yokosuka Kyosai Hospital, Yokosuka, , Japan
Severance Hospital, Yonsei University Health System, Seoul, , Korea, Republic of
Samsung Medical Center, Seoul, , Korea, Republic of
Catholic Medical Center, Seoul, , Korea, Republic of
Chang Gung Memorial Hospital, Taoyuan City, , Taiwan
Contact Details
Name: Johnson & Johnson International (Singapore) Pte Ltd Clinical Trial
Affiliation: Johnson & Johnson International (Singapore) Pte. Ltd.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
